Video

The FDA Perspective on CAPA

At IVT's 12th Annual Change Control, Joseph Zec outlined the US Food and Drug Administration's expectations for a company's corrective and preventive action (CAPA), as outlined in Code of Federal Regulations Title 21 Part 820. In this presentation, Zec analyzed the regulatory requirements for CAPA in terms of identification and investigation, verification, dissemination of information, and submission for approval.

See more of Joseph Zec, IVT Speaker of the Year, at Validation Week.

Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.

Comments (0)

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.
Image CAPTCHA
Enter the characters shown in the image.